Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-12-31
1998-06-16
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 85, 514312, 514562, A61K 3147, A61K 31195, A61K 3150, A61K 31495, A61K 31675
Patent
active
057671192
ABSTRACT:
The present invention is a pharmaceutical composition having a combination of an uricosuric agent such as probenecid or the like and an excitatory amino acid antagonist useful for treating a disease advantageously affected by treatment with an excitatory amino acid antagonist.
REFERENCES:
patent: 4812458 (1989-03-01), Honore et al.
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 5407935 (1995-04-01), Bigge et al.
CA 117:131090, Carling et al., 1992.
CA 78:106053v, Andersson et al., 1973.
CA 86:11703h, Walters et al, 1976.
CA 87:126928y, Domer et al, 1977.
CA 97:85942j, Laescher et al, 1982.
PCT Search Report, PCT/US92/07540.
European Journal of Pharmacology, vol. 213, No. 1, Mar. 1992, Taylor et al., pp. 151-153.
Dissertation of Arzu Selen (Abstract only), i-iii (1984).
Neuroscience Letters, 84 (1988) 339-344.
Neuroscience Letters, 37 (1983) 75-80.
Pharmacology 1990; 40:1-7.
Advances in Pharmacology 4:91-142 (1966).
Arch. Int. Pharmacodyn. XCVIII, No. 1 97-117 (1954).
Bull. Johns Hopkins Hospital 156:333-346 (1960).
Pharmac. Res. 7(4):411-417 (1990).
Goodman and Gilman, 8th ed. pp. 745-746 (1984).
Clinical Pharmacokinetics 6:135-151 (1981).
"The Influence of a New Benzoic Acid Derivative of the Metabolism of Paraaminosalicylic Acid (PAS) and Penicillin" as presented before the 31st Annual Session of the American College of Physicians, Boston, Apr., 1950.
Clinical Pharmacology and Therapeutics 9(3):345-349 (1968).
Acta Neurol. Scandinav. 45:253-256 (1969).
Psychopharmacologia (Berl.) 25:96-100 (1972).
The Journal of Pharmacology and Experimental Therapeutics, vol. 188, No. 1, 55-65 (1974).
Eur. J. Clin. Pharmacol. 17:223-226 (1980).
Psychopharmacology 52:35-40 (1977).
Cancer Research 40:2184-2187 (Jul. 1980).
Journal of Pharmaceutical Sciences 78(9):716-22 (Sep. 1989).
Pharmaceutical Research 7(4):332-338 (1990).
Neuroscience Letters 37:75-80 (1983).
Neuroscience Letters 84:339-344 (1988).
J. Pharmacobio-Dyn., 13:158-163 (1990).
Oldendorf, W., "Certain Aspects of Drug Distribution to Brain" pp. 103-109 (1976).
The Lancet, Jul. 20, 1985, pp. 140-143.
Choi, Dennis W., "Glutamate Neurotoxicity and Disease of the Nervous System" pp. 623-634 (1988).
Excitatory Amino Acid Antagonists, pp. 34-53 (1988).
Journal of Pharmaceutical Sciences 71(11):1238-1241 (Nov. 1982).
Bigge Christopher Franklin
Johnson Graham
Taylor, Jr. Charles Price
Welty Devin Franklin
Crissey Todd M.
Jordan Kimberly
Warner-Lambert & Company
LandOfFree
Method of treating neurodegenerative diseases using an AMPA exci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating neurodegenerative diseases using an AMPA exci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating neurodegenerative diseases using an AMPA exci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726292